Clinic
First Medcare, INC.
First Medcare, INC. was paid $12.09M by Medicaid between Jan 2018 and Dec 2024, across 130 billing codes. Its largest line is D1120, dental cleaning, child — 19% of everything it billed.
33Billing provider infoFIRST MEDCARE, INC.
BROOKLYN, NY 11236
BROOKLYN, NY 11236
33aNPI1578625950assigned 12/14/2006
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$12.09M
24GClaims405,980
24DCodes billed130
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Multi-Specialty Clinic/Center providers in New York
Rank by total paid#12 of 118
Median peer was paid$372K
This provider vs. median33×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 53,155 | $2.44M | |
| 2019 | 74,897 | $3.30M | |
| 2020 | 42,689 | $1.40M | |
| 2021 | 36,303 | $932K | |
| 2022 | 127,816 | $2.31M | |
| 2023 | 40,272 | $928K | |
| 2024incomplete | 30,848 | $795K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| D1120 | Dental cleaning, childProphylaxis - child | 19% | 45,317 | 11,486 | $2.30M |
| D1330 | 13% | 32,244 | 8,792 | $1.62M | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11% | 20,907 | 11,703 | $1.29M |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 8.5% | 55,137 | 31,772 | $1.02M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.5% | 21,781 | 7,753 | $783K |
| D1206 | Topical application of fluoride varnish | 6.2% | 14,606 | 4,766 | $745K |
| D0150 | Comprehensive oral evaluation - new or established patient | 4.5% | 10,950 | 3,736 | $550K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 4.5% | 7,559 | 1,393 | $543K |
| D0120 | Dental checkup, returning patientPeriodic oral evaluation - established patient | 2.9% | 9,767 | 6,326 | $349K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.9% | 1,995 | 1,853 | $224K |
| D0190 | 1.8% | 5,262 | 2,374 | $221K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 1.6% | 3,562 | 3,129 | $195K |
118 more codes
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.6% | 30,272 | $193K |
| D1110 | Prophylaxis - adult | 1.5% | 5,195 | $176K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.3% | 2,219 | $160K |
| 99203 | Doctor's office visit, new patient (routine) | 1.3% | 1,486 | $154K |
| 99401 | 1.2% | 4,909 | $151K | |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 3,760 | $117K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 6,668 | $116K |
| 10040 | <1% | 643 | $97K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 707 | $78K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,030 | $74K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 819 | $72K |
| D0274 | Bitewings - four radiographic images | <1% | 4,210 | $71K |
| 92060 | <1% | 2,681 | $69K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 604 | $69K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 591 | $63K |
| 17360 | <1% | 711 | $62K | |
| T1017 | Case management, billed per 15 minutes | <1% | 2,868 | $59K |
| 99441 | <1% | 357 | $43K | |
| 86328 | <1% | 1,025 | $38K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 246 | $30K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 2,345 | $28K |
| D0330 | Panoramic radiographic image | <1% | 996 | $27K |
| 11900 | <1% | 104 | $23K | |
| 97129 | <1% | 258 | $18K | |
| 92551 | <1% | 260 | $17K | |
| 92557 | <1% | 854 | $17K | |
| 11901 | <1% | 76 | $14K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 300 | $12K |
| D1351 | Sealant - per tooth | <1% | 311 | $11K |
| 99385 | <1% | 140 | $11K | |
| 11720 | <1% | 431 | $11K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,205 | $10K |
| 92201 | <1% | 111 | $10K | |
| 11721 | <1% | 1,429 | $10K | |
| D0140 | Limited oral evaluation - problem focused | <1% | 737 | $10K |
| D0210 | Intraoral - complete series of radiographic images | <1% | 550 | $9K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 129 | $9K |
| D0220 | Intraoral - periapical first radiographic image | <1% | 976 | $9K |
| 97116 | <1% | 110 | $8K | |
| D9920 | <1% | 152 | $8K | |
| 96112 | <1% | 21 | $7K | |
| 97130 | <1% | 89 | $6K | |
| 99173 | <1% | 277 | $6K | |
| 90630 | <1% | 264 | $6K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 52 | $5K |
| 90682 | <1% | 260 | $5K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 276 | $5K |
| 90686 | <1% | 226 | $4K | |
| D4910 | <1% | 31 | $4K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 41 | $4K |
| 99442 | <1% | 34 | $4K | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 81 | $3K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 672 | $3K |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 87 | $3K |
| 96160 | <1% | 54 | $3K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,307 | $3K |
| 92020 | <1% | 30 | $2K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 16 | $2K |
| 99386 | <1% | 40 | $2K | |
| 90715 | <1% | 104 | $2K | |
| 92133 | <1% | 46 | $2K | |
| 76512 | <1% | 277 | $2K | |
| 99050 | <1% | 297 | $2K | |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 43 | $2K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 12 | $1K |
| 99490 | Ccm add 20min | <1% | 13 | $850.57 |
| 1111F | <1% | 9,797 | $832.33 | |
| 92083 | <1% | 26 | $803.56 | |
| 92250 | <1% | 26 | $803.56 | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 12 | $754.68 |
| 99406 | <1% | 17 | $596.89 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 87 | $563.58 |
| G0008 | Administration of influenza virus vaccine | <1% | 51 | $562.06 |
| 90649 | <1% | 13 | $558.94 | |
| D4341 | <1% | 34 | $514.18 | |
| 93000 | <1% | 1,276 | $509.64 | |
| 96127 | <1% | 537 | $454.84 | |
| 92134 | <1% | 14 | $393.41 | |
| 90656 | <1% | 38 | $363.09 | |
| 0011A | <1% | 13 | $359.94 | |
| 99497 | <1% | 35 | $323.50 | |
| 0012A | <1% | 20 | $303.34 | |
| 92015 | Determination of refractive state | <1% | 18 | $251.07 |
| 92226 | <1% | 201 | $240.53 | |
| 81003 | <1% | 1,573 | $215.75 | |
| 82962 | <1% | 1,271 | $161.01 | |
| 99051 | <1% | 12 | $152.28 | |
| 90633 | <1% | 13 | $149.93 | |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 16 | $128.47 |
| 90461 | <1% | 36 | $99.77 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 14 | $45.87 |
| 3078F | <1% | 6,683 | $41.17 | |
| 3074F | <1% | 7,351 | $37.02 | |
| 81025 | <1% | 40 | $26.31 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 595 | $17.69 |
| 94760 | <1% | 179 | $2.70 | |
| 81002 | <1% | 90 | $2.00 | |
| 1159F | <1% | 10,896 | $2.00 | |
| 1157F | <1% | 3,463 | $1.01 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | <1% | 202 | $0.15 |
| 3077F | 0% | 2,093 | $0.00 | |
| 1160F | 0% | 3,389 | $0.00 | |
| 0521F | 0% | 1,150 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 18 | $0.00 |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 201 | $0.00 |
| 99080 | 0% | 38 | $0.00 | |
| 99072 | 0% | 29 | $0.00 | |
| 1126F | 0% | 10,563 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 14,182 | $0.00 |
| 1170F | 0% | 2,752 | $0.00 | |
| 1125F | 0% | 1,161 | $0.00 | |
| 3075F | 0% | 2,213 | $0.00 | |
| 3008F | 0% | 253 | $0.00 | |
| 3080F | 0% | 1,292 | $0.00 | |
| 3079F | 0% | 3,730 | $0.00 | |
| 91301 | 0% | 20 | $0.00 | |
| 3044F | 0% | 12 | $0.00 | |
| 94761 | 0% | 23 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKLEIN, GERSHON (PRESIDENT)